Neon Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NTGN and buy or sell other stocks, ETFs, and their options commission-free!

About NTGN

BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. 

CEO
Hugh O'Dowd, MBA
CEOHugh O'Dowd, MBA
Employees
—
Employees—
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
—
Employees—

NTGN Key Statistics

Market cap
88.93M
Market cap88.93M
Price-Earnings ratio
-1.14
Price-Earnings ratio-1.14
Dividend yield
—
Dividend yield—
Average volume
665.16K
Average volume665.16K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$5.97
52 Week high$5.97
52 Week low
$0.88
52 Week low$0.88

People also own

Based on the portfolios of people who own NTGN. This list is generated using Robinhood data, and it’s not a recommendation.
Plug Power
Inovio
Viking Therapeutics
Aurora Cannabis
Hexo
Verastem
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.